Description
EXERCISE OY2
First action · last action
2025-10-01 · 2025-10-01
Transactions
1
First transaction's obligation
$12,949
Base + all options value (sum of deltas)
$12,949
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE-OTHER (FAR 6.302-1 OTHER)
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
36C26323D0117
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2025-10-01+$12,949= $12,949
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2025-10-01 | +$12,949 | $12,949 | EXERCISE OY2 |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI FGK2QR959BV5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24926N0641 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $172,138 | FY2026 |
| 36C24426A0041 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · Q999 · MEDICAL- OTHER | $0 | FY2026 |
| 36C24426N0964 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $45,218 | FY2026 |
| 36C24426N0963 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $244,586 | FY2026 |
| 36C26026N0382 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · Q301 · REFERENCE LABORATORY TESTING | $125,000 | FY2026 |
| 36C24426N0738 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $78,181 | FY2026 |
Other recipients under 6550 from NETWORK CONTRACT OFFICE 23 (36C263) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C26326P0546 | ROCHE DIAGNOSTICS CORPORATION | NETWORK CONTRACT OFFICE 23 (36C263) | $262,620 | FY2026 |
| 36C26326D0057 | PROMEGA CORPORATION | NETWORK CONTRACT OFFICE 23 (36C263) | $0 | FY2026 |
| 36C26326N0540 | PROMEGA CORPORATION | NETWORK CONTRACT OFFICE 23 (36C263) | $24,378 | FY2026 |
| 36C26326N0012 | BIOMERIEUX INC | NETWORK CONTRACT OFFICE 23 (36C263) | $70,608 | FY2026 |
| 36C26326N0005 | MICROGENICS CORPORATION | NETWORK CONTRACT OFFICE 23 (36C263) | $165,318 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26326N0032_3600_36C26323D0117_3600 · retrieved 2026-09-26.